Clovis taps Qiagen to develop companion IVD for lung cancer drug
This article was originally published in Clinica
Executive Summary
Clovis Oncology has partnered up with Qiagen to develop a companion diagnostic test for the former’s promising drug candidate, CO-1686, in development as a treatment for non-small cell lung cancer (NSCLC).